PT Bundamedik TbkISX:BMHS +1.15%61 Days Payable is 37.63 as of Mar. 2026, which is 20% below its 10-year median of 46.92. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp306.37 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, PT Bundamedik Tbk ranks worse than 78.18% on this metric.
The historical rank and industry rank for PT Bundamedik Tbk's Days Payable or its related term are showing as below:
ISX:BMHS'
s Days Payable Range Over the Past 10 Years
Min: 18.66 Med: 46.92 Max: 71.67
Current: 25.46
During the past 8 years, PT Bundamedik Tbk's highest Days Payable was 71.67. The lowest was 18.66. And the median was 46.92.
ISX:BMHS's Days Payable is ranked worse than 78.18% of 605
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs ISX:BMHS: 25.46
PT Bundamedik Tbk's Days Payable
increased
from Mar. 2025 (16.90) to Mar. 2026 (37.63).
It may suggest that PT Bundamedik Tbkdelayed paying its suppliers.
PT Bundamedik Tbk Days Payable Related Terms
PT Bundamedik Tbk Days Payable Historical Data
* Premium members only.
The historical data trend for PT Bundamedik Tbk's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:BMHS vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Bundamedik Tbk Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Bundamedik Tbk's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Bundamedik Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Bundamedik Tbk (ISX:BMHS) has a Days Payable of 37.63 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Bundamedik Tbk and its competitors. This is 20% below median its historical median of 46.92. Over the past decade, PT Bundamedik Tbk's Days Payable has ranged from 18.66 to 71.67. According to the industry distribution chart, PT Bundamedik Tbk ranks #473 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 78.2%.
Is PT Bundamedik Tbk's Days Payable too high?
PT Bundamedik Tbk's current Days Payable of 37.63 is 20% below median its 10-year median of 46.92. Over the past 10 years, this metric has ranged from a low of 18.66 to a high of 71.67. The Healthcare Providers & Services industry median Days Payable is 58.00. PT Bundamedik Tbk's value of 37.63 is 35.1% below this industry median. Based on the distribution chart, PT Bundamedik Tbk ranks #473 out of 605 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Bundamedik Tbk ranks #473 out of 605 companies for Days Payable. This places PT Bundamedik Tbk in the lower half of its industry. The industry median Days Payable is 58.00. PT Bundamedik Tbk's value of 37.63 is 35.1% below this benchmark. Historically, PT Bundamedik Tbk's own Days Payable has ranged from 18.66 to 71.67 over the past decade. While the company's 10-year median is 46.92 vs. the industry median of 58.00, PT Bundamedik Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Bundamedik Tbk's current Days Payable of 37.63 is 35.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Bundamedik Tbk and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Bundamedik Tbk's current Days Payable is 37.63, which is 20% below median its own 10-year median of 46.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp306.37, compared to a current price of Rp176.00 — trading 42.6% below its estimated fair value. The current Days Payable is 37.63, which is 20% below median its 10-year median of 46.92 and 35.1% below the Healthcare Providers & Services industry median of 58.00. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Days Payable is 37.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued.
The current stock price of Rp176.00 is trading 42.6% below its estimated GF Value™ of Rp306.37.
GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.
Key valuation signals for ISX:BMHS:
Days Payable: 37.63 (20% below median its 10-year median of 46.92)
GF Value™: Rp306.37 vs. price of Rp176.00 (42.6% below fair value)
Industry Position: 35.1% below the Healthcare Providers & Services median (#473 of 605)
No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score
Get the complete analysis for ISX:BMHS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:BMHS has been successfully added to your 
